Details for New Drug Application (NDA): 020597

✉ Email this page to a colleague

NDA 020597 describes XALATAN, which is a drug marketed by Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the XALATAN profile page.

The generic ingredient in XALATAN is latanoprost. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.

Summary for 020597

Tradename:	XALATAN
Applicant:	Upjohn
Ingredient:	latanoprost
Patents:	0

Suppliers and Packaging for NDA: 020597

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
XALATAN	latanoprost	SOLUTION/DROPS;OPHTHALMIC	020597	NDA	Viatris Specialty LLC	58151-419	58151-419-35	1 BOTTLE, DROPPER in 1 CARTON (58151-419-35) / 2.5 mL in 1 BOTTLE, DROPPER
XALATAN	latanoprost	SOLUTION/DROPS;OPHTHALMIC	020597	NDA AUTHORIZED GENERIC	Mylan Pharmaceuticals Inc.	59762-0333	59762-0333-2	1 BOTTLE, DROPPER in 1 CARTON (59762-0333-2) / 2.5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.005%
Approval Date:	Jun 5, 1996	TE:	AT	RLD:	Yes

Expired US Patents for NDA 020597

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Upjohn	XALATAN	latanoprost	SOLUTION/DROPS;OPHTHALMIC	020597-001	Jun 5, 1996	⤷ Get Started Free	⤷ Get Started Free
Upjohn	XALATAN	latanoprost	SOLUTION/DROPS;OPHTHALMIC	020597-001	Jun 5, 1996	⤷ Get Started Free	⤷ Get Started Free
Upjohn	XALATAN	latanoprost	SOLUTION/DROPS;OPHTHALMIC	020597-001	Jun 5, 1996	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.